Department of Chemistry and Biochemistry, UC Santa Cruz, Santa Cruz, CA 95064, USA.
Angew Chem Int Ed Engl. 2022 Sep 19;61(38):e202208029. doi: 10.1002/anie.202208029. Epub 2022 Aug 16.
We report the first total synthesis of an antimycobacterial natural product oxazinin A that takes advantage of a multi-component cascade reaction of anthranilic acid and a precursor polyketide containing an aldehyde. The route utilized for the synthesis of the pseudodimeric oxazinin A validates a previously proposed biosynthetic mechanism, invoking a non-enzymatic pathway to the complex molecule. We found a 76 : 10 : 9 : 5 ratio of oxazinin diastereomers from the synthetic cascade, which is an identical match to that found in the fermentation media from the fungus Eurotiomycetes 110162. Further investigation of the non-enzymatic formation of oxazinin A using H- N HMBC NMR spectroscopy allowed for a plausible determination of the stepwise mechanism. The developed route is highly amenable for the synthesis of diverse sets of analogs around the oxazinin scaffold to study structure-activity relationships (SAR).
我们报告了抗分枝杆菌天然产物恶嗪因 A 的首次全合成,该合成利用了邻氨基苯甲酸和含有醛基的前体聚酮的多组分级联反应。该路线用于合成伪二聚体恶嗪因 A,验证了先前提出的生物合成机制,即涉及到复杂分子的非酶途径。我们从合成级联反应中发现了恶嗪因非对映异构体的 76:10:9:5 比例,与真菌 Eurotiomycetes 110162 的发酵培养基中发现的比例完全一致。使用 H-N HMBC NMR 光谱进一步研究恶嗪因 A 的非酶形成,使逐步机制的合理确定成为可能。所开发的路线非常适合在恶嗪因支架周围合成各种类似物,以研究结构-活性关系 (SAR)。